JPRN-UMIN000013390已完成2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. - Phase II study of weekly nab-PTX in patients with NSCLC previously treated with platinum-based chemotherapy.
ational Hospital Organization Asahikawa Medical center0 个研究点目标入组 40 人开始时间: 2014年3月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Previous treatment with paclitaxel (2) Patients who remain influence of prior treatment which disturb protocol treatment (3) Symptomatic brain metastasis 4) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 5) Active infection requiring administration of systemic treatment with antibiotics. e.g. Body temperature rose higher than 38 degree centigrade 6) Severe complication(s), e.g., paresis of intestines, ileus, radiographically confirmed interstitial pneumonitis (except documented radiation pneumonitis) or pulmonary fibrosis, poorly-controlled diabetes, cardiac failure, renal failure, liver failure, active gastrointestinal ulceration, myocardial infarction within 6 months, and Grade 3 or higher angina 7) Patients with autoimmune disease requiring treatment with an immunosuppressive agent such as azathiopurine, chlorambucil, cyclophosphamide, ciclosporin, methotrexate, and steroids 8) Active double cancer (synchronous cancer, or metachronous cancer with less than 5 years of disease-free interval), except in situ cervical cancer cured by local treatment, gastric or colon cancer curatively resectable with endoscopy, and resectable non-melanoma skin cancer 9) Confirmed or possible pregnancy, lactation, willingness to become pregnant (for women), or willingness to have a child (for men) 10) Psychiatric disorder or symptom that makes participation of the patient difficult 11) Continuous administration of a steroid 12) Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
招募中
不适用
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast CancerBreast cancerJPRN-UMIN000005979Wakayama Medical University50
已完成
1 期
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer (NJLCG1402)on-small cell lung cancerJPRN-UMIN000014893orth Japan Lung Cancer Study Group (NJLCG)42
已完成
2 期
A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast cancerJPRN-UMIN000007510ahanishi Clinic30
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20